333 related articles for article (PubMed ID: 18656797)
1. Post-transplant colonization with non-Aspergillus molds and risk of development of invasive fungal disease in lung transplant recipients.
Silveira FP; Kwak EJ; Paterson DL; Pilewski JM; McCurry KR; Husain S
J Heart Lung Transplant; 2008 Aug; 27(8):850-5. PubMed ID: 18656797
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K
Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients.
Neofytos D; Fishman JA; Horn D; Anaissie E; Chang CH; Olyaei A; Pfaller M; Steinbach WJ; Webster KM; Marr KA
Transpl Infect Dis; 2010 Jun; 12(3):220-9. PubMed ID: 20113459
[TBL] [Abstract][Full Text] [Related]
4. Preemptive treatment with voriconazole in lung transplant recipients.
Neoh CF; Snell GI; Levvey B; Kotsimbos T; Morrissey CO; Slavin MA; Stewart K; Kong DC
Transpl Infect Dis; 2013 Aug; 15(4):344-53. PubMed ID: 23527908
[TBL] [Abstract][Full Text] [Related]
5. Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi.
Husain S; Alexander BD; Munoz P; Avery RK; Houston S; Pruett T; Jacobs R; Dominguez EA; Tollemar JG; Baumgarten K; Yu CM; Wagener MM; Linden P; Kusne S; Singh N
Clin Infect Dis; 2003 Jul; 37(2):221-9. PubMed ID: 12856215
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of invasive aspergillosis in lung transplant recipients by detection of galactomannan in the bronchoalveolar lavage fluid.
Pasqualotto AC; Xavier MO; Sánchez LB; de Oliveira Costa CD; Schio SM; Camargo SM; Camargo JJ; Sukiennik TC; Severo LC
Transplantation; 2010 Aug; 90(3):306-11. PubMed ID: 20548265
[TBL] [Abstract][Full Text] [Related]
7. Invasive fungal infections in lung transplant recipients not receiving routine systemic antifungal prophylaxis: 12-year experience at a university lung transplant center.
Pinney MF; Rosenberg AF; Hampp C; Schain D; Akindipe O; Baz M
Pharmacotherapy; 2011 Jun; 31(6):537-45. PubMed ID: 21923437
[TBL] [Abstract][Full Text] [Related]
8. Trends in invasive disease due to Candida species following heart and lung transplantation.
Schaenman JM; Rosso F; Austin JM; Baron EJ; Gamberg P; Miller J; Oyer PE; Robbins RC; Montoya JG
Transpl Infect Dis; 2009 Apr; 11(2):112-21. PubMed ID: 19254327
[TBL] [Abstract][Full Text] [Related]
9. Fungi and molds following lung transplantation.
Hosseini-Moghaddam SM; Husain S
Semin Respir Crit Care Med; 2010 Apr; 31(2):222-33. PubMed ID: 20354934
[TBL] [Abstract][Full Text] [Related]
10. Aspergillus galactomannan antigen in the bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in lung transplant recipients.
Husain S; Paterson DL; Studer SM; Crespo M; Pilewski J; Durkin M; Wheat JL; Johnson B; McLaughlin L; Bentsen C; McCurry KR; Singh N
Transplantation; 2007 May; 83(10):1330-6. PubMed ID: 17519782
[TBL] [Abstract][Full Text] [Related]
11. Spectrum and risk factors for invasive candidiasis and non-Candida fungal infections after liver transplantation.
Shi SH; Lu AW; Shen Y; Jia CK; Wang WL; Xie HY; Zhang M; Liang TB; Zheng SS
Chin Med J (Engl); 2008 Apr; 121(7):625-30. PubMed ID: 18466683
[TBL] [Abstract][Full Text] [Related]
12. [Surveillance of invasive mold infections in lung transplant recipients: effect of antimycotic prophylaxis with itraconazole and voriconazole].
Mattner F; Chaberny IF; Weissbrodt H; Fischer S; Gastmeier P; Haubitz B; Gottlieb J; Mattner L; Strueber M
Mycoses; 2005; 48 Suppl 1():51-5. PubMed ID: 15826288
[TBL] [Abstract][Full Text] [Related]
13. Invasive mold infections in lung and heart-lung transplant recipients: Stanford University experience.
Vazquez R; Vazquez-Guillamet MC; Suarez J; Mooney J; Montoya JG; Dhillon GS
Transpl Infect Dis; 2015 Apr; 17(2):259-66. PubMed ID: 25648194
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of bronchoalveolar lavage neutrophilia in stable lung transplant recipients.
Neurohr C; Huppmann P; Samweber B; Leuschner S; Zimmermann G; Leuchte H; Baumgartner R; Hatz R; Frey L; Ueberfuhr P; Bittmann I; Behr J;
J Heart Lung Transplant; 2009 May; 28(5):468-74. PubMed ID: 19416775
[TBL] [Abstract][Full Text] [Related]
15. The significance of isolation of saprophytic molds from the lower respiratory tract in patients with cancer.
Lionakis MS; Kontoyiannis DP
Cancer; 2004 Jan; 100(1):165-72. PubMed ID: 14692037
[TBL] [Abstract][Full Text] [Related]
16. Invasive pulmonary aspergillosis following bone marrow transplantation: risk factors and diagnostic aspect.
Soubani AO; Qureshi MA
Haematologia (Budap); 2002; 32(4):427-37. PubMed ID: 12803117
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of invasive respiratory disease caused by emerging non-Aspergillus molds in lung transplant recipients.
Peghin M; Monforte V; Martin-Gomez MT; Ruiz-Camps I; Berastegui C; Saez B; Riera J; Solé J; Gavaldá J; Roman A
Transpl Infect Dis; 2016 Feb; 18(1):70-8. PubMed ID: 26678668
[TBL] [Abstract][Full Text] [Related]
18. Prospective interventional study to evaluate the efficacy and safety of liposomal amphotericin B as prophylaxis of fungal infections in high-risk liver transplant recipients.
Castroagudín JF; Pontón C; Bustamante M; Otero E; Martínez J; Tomé S; Conde R; Segade FR; Delgado M; Brage A; Galbán C; Varo E
Transplant Proc; 2005 Nov; 37(9):3965-7. PubMed ID: 16386598
[TBL] [Abstract][Full Text] [Related]
19. Challenges in the diagnosis and management of Nocardia infections in lung transplant recipients.
Poonyagariyagorn HK; Gershman A; Avery R; Minai O; Blazey H; Asamoto K; Alster J; Murthy S; Mehta A; Pettersson G; Mason DP; Budev M
Transpl Infect Dis; 2008 Dec; 10(6):403-8. PubMed ID: 18823356
[TBL] [Abstract][Full Text] [Related]
20. Risk stratification and targeted antifungal prophylaxis for prevention of aspergillosis and other invasive mold infections after liver transplantation.
Hellinger WC; Bonatti H; Yao JD; Alvarez S; Brumble LM; Keating MR; Mendez JC; Kramer DJ; Dickson RC; Harnois DM; Spivey JR; Hughes CB; Nguyen JH; Steers JL
Liver Transpl; 2005 Jun; 11(6):656-62. PubMed ID: 15915482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
